Molnupiravir
Molnupiravir is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in adults who have mild to moderate symptoms and are at risk of severe disease that could result in hospitalization or death when other treatments are either not available or cannot be used.
United States
$438
per month
India
$1
per month
You save
−99.73%save $437/mo · 99.73% cheaper
206.7K US scripts/yr$90.4M potential annual savings$90.6M US spend/yr
Drag to rotate · 3D structureC13H19N3O7
SMILES: CC(C)C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)NO)O)O
Compare the price
US price$438per month
India price$1per month
You save$43799.73% less
Based on 30 units per month. US $14.61 vs India $0.04 per unit.
Total over 1 periodSave $437$438 → $1
The bigger picture
Molnupiravir is filled about 206.7K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$90.6M
If sourced from India
$241.9K
Potential annual savings
$90.4M
−100%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.